Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus.

Saved in:
Bibliographic Details
Title: Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus.
Authors: Sax PE; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Rockstroh JK; University Hospital Bonn, Bonn, Germany., Luetkemeyer AF; University of California, San Francisco, San Francisco, California, USA., Yazdanpanah Y; Hôpital Bichat Claude Bernard, Paris, France., Ward D; Dupont Circle Physicians, Washington, District of Columbia, USA., Trottier B; Clinique de Medecine Urbaine du Quartier Latin, Montreal, Quebec, Canada., Rieger A; University of Vienna Medical School, Vienna, Austria., Liu H; Gilead Sciences, Foster City, California, USA., Acosta R; Gilead Sciences, Foster City, California, USA., Collins SE; Gilead Sciences, Foster City, California, USA., Brainard DM; Gilead Sciences, Foster City, California, USA., Martin H; Gilead Sciences, Foster City, California, USA.
Corporate Authors: GS-US-380–4030 Investigators
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 15; Vol. 73 (2), pp. e485-e493.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Equivalence Trial
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-6591
DOI:10.1093/cid/ciaa988